Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

lorundrostatMZE829rilparencelNeutral

AI Analysis

Summary

Market analysis article discussing five emerging therapies in development for chronic kidney disease, including lorundrostat, MZE829, and rilparencel, with expectations of increased competition in the treatment landscape by 2036.

Importance:2/10

Sentiment:

0.00

chronic kidney diseaselate-stage pipelineendothelin receptor antagonistsaldosterone synthase inhibitorsAPOL1 inhibitorscell therapymarket analysis

Related Companies

$DHCNL

Read the original article

Published by PR Newswire Biotech on September 24, 2026 2:31 PM

Read Original